Matches in Wikidata for { <http://www.wikidata.org/entity/Q70762328> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q70762328 description "article scientifique publié en 1984" @default.
- Q70762328 description "artículu científicu espublizáu n'avientu de 1984" @default.
- Q70762328 description "im Dezember 1984 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70762328 description "scientific article published on 01 December 1984" @default.
- Q70762328 description "wetenschappelijk artikel" @default.
- Q70762328 description "наукова стаття, опублікована в грудні 1984" @default.
- Q70762328 name "Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group" @default.
- Q70762328 name "Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group" @default.
- Q70762328 type Item @default.
- Q70762328 label "Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group" @default.
- Q70762328 label "Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group" @default.
- Q70762328 prefLabel "Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group" @default.
- Q70762328 prefLabel "Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group" @default.
- Q70762328 P1433 Q70762328-B9B129CF-329C-4AB8-ACAD-450CA03637E2 @default.
- Q70762328 P1476 Q70762328-7CAFFE90-E29A-4A6B-AD0A-2EC6980F560F @default.
- Q70762328 P2093 Q70762328-9D81E39B-82F0-4759-91D4-AAD2604B0C06 @default.
- Q70762328 P2093 Q70762328-A2EF4215-6110-4033-95B9-A64EFA6ED76D @default.
- Q70762328 P2093 Q70762328-BFED3D3A-30F0-4ADD-A2E0-BAF0C9B89BD8 @default.
- Q70762328 P2093 Q70762328-CBDC962F-BD22-4212-8D8E-480358794DE3 @default.
- Q70762328 P304 Q70762328-A2827DE9-1556-470D-9A14-958756F5E2F4 @default.
- Q70762328 P31 Q70762328-5E5D1EEA-0AFB-4994-9B3E-B239F8E74D8A @default.
- Q70762328 P356 Q70762328-78D94CA8-8D24-4351-BCD4-078E44228B14 @default.
- Q70762328 P433 Q70762328-FD875882-F35B-4D62-B5F4-65783D390DBF @default.
- Q70762328 P478 Q70762328-1A261BB7-D313-4A4B-9B3A-A90E8708E454 @default.
- Q70762328 P50 Q70762328-A7EA56F7-32E9-4CF2-A46E-34B0ED8F7051 @default.
- Q70762328 P577 Q70762328-D785B2F1-628C-4736-89F8-DA44ED6AF3BB @default.
- Q70762328 P698 Q70762328-94ACE53E-1435-4C71-BE59-1E21259A4DE2 @default.
- Q70762328 P921 Q70762328-3F21D54D-DE24-4147-B325-0E148C8829FA @default.
- Q70762328 P356 00000421-198412000-00026 @default.
- Q70762328 P698 6528868 @default.
- Q70762328 P1433 Q2886177 @default.
- Q70762328 P1476 "Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group" @default.
- Q70762328 P2093 "B Bundy" @default.
- Q70762328 P2093 "C E Ehrlich" @default.
- Q70762328 P2093 "J Graham" @default.
- Q70762328 P2093 "R Asbury" @default.
- Q70762328 P304 "737-739" @default.
- Q70762328 P31 Q13442814 @default.
- Q70762328 P356 "10.1097/00000421-198412000-00026" @default.
- Q70762328 P433 "6" @default.
- Q70762328 P478 "7" @default.
- Q70762328 P50 Q104758257 @default.
- Q70762328 P577 "1984-12-01T00:00:00Z" @default.
- Q70762328 P698 "6528868" @default.
- Q70762328 P921 Q5625186 @default.